Quantcast
Channel: メディカルプレスセンター QLifePro »研究
Browsing all 7771 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

First-Ever Tang Prize Opens with a Week of Celebration

  TAIPEI, Taiwan After a very careful nomination and selection process, the first winners of the inaugural Tang Prize were announced over four days of announcements starting on June 18, 2014, one day...

View Article


Image may be NSFW.
Clik here to view.

Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI...

  HENDERSON, Nev. & ROCKVILLE, Md. Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in...

View Article


Image may be NSFW.
Clik here to view.

United Health Products Inc. Announces St John Ambulance to Implement Hemostyp...

  HENDERSON, Nev. United Health Products, Inc. (OTCQB: UEEC) announced that its Australian Distributor Critical Health, in conjunction with their key partner, has secured the first order from St John...

View Article

Image may be NSFW.
Clik here to view.

RxAdvance Expands Executive Management Team

  SOUTHBOROUGH, Mass. RxAdvance, an innovative pharmacy benefit management (PBM) company, has expanded its executive management team with another industry veteran, Terry A. Ramey, who joins as...

View Article

Image may be NSFW.
Clik here to view.

MSD呈报研究新药Omarigliptin(每周一次给药的DPP-4抑制剂)用于日本2型糖尿病患者的首批3期数据

  维也纳 (美国商业资讯) — MSD在美国和加拿大又名默克(NYSE:MRK),该公司今天发布了研究新药omarigliptin(每周一次给药的DPP-4抑制剂)治疗2型糖尿病的3期临床开发项目的首批数据。该研究显示,在日本患者中,omarigliptin的有效性和耐受性与MSD的每周一次给药的DPP-4抑制剂捷诺维® (西格列汀)50毫克相等,50毫克是西格列汀在日本的标准起始剂量。1...

View Article


Image may be NSFW.
Clik here to view.

MSDが2型糖尿病治験薬の週1回投与型DPP-4阻害薬オマリグリプチンの日本人患者における初の第3相データを発表

  ウィーン (ビジネスワイヤ) —...

View Article

Image may be NSFW.
Clik here to view.

Jinchi Biotech Ltd Launched Its ANDRIAS E-Commerce Flagship Store in Tmall

  ZHANGJIAJIE, China Jinchi Biotech Ltd. had opened its ANDRIAS E-Commerce Flagship Store in Tmall.com (ANDRIAS Tmall Flagship Store Website: XIANGNI.TMALL.COM). As the unique brand of giant...

View Article

Image may be NSFW.
Clik here to view.

Institut Pasteur de Montevideo, Genomic Medicine Institute-Seoul National...

  SEOUL, South Korea Institut Pasteur de Montevideo (Uruguay), Genomic Medicine Institute- Seoul National University (GMI-SNU, South Korea) and Macrogen Inc. ( KRX 038290) (South Korea) have announced...

View Article


Image may be NSFW.
Clik here to view.

アジレント・テクノロジーズが最高経営責任者(CEO)の交代を発表:2015年3月にビル・サリバンからマイク・マクマレンへ

  米カリフォルニア州サンタクララ (ビジネスワイヤ) —...

View Article


Image may be NSFW.
Clik here to view.

安捷伦科技宣布首席执行官人事接任计划:Mike McMullen将于2015年3月接替Bill Sullivan担任首席执行官

  加州圣塔克拉拉 (美国商业资讯)–安捷伦科技公司(Agilent Technologies Inc., NYSE:A)今天宣布,安捷伦高级副总裁兼公司化学分析集团(CAG)总裁Mike McMullen将于2015年3月18日接替William (Bill) Sullivan担任首席执行官。Sullivan将在2015年10月31日该公司财年结束之前继续担任该公司顾问,随后将正式退休。...

View Article

Image may be NSFW.
Clik here to view.

Telormedix Granted European Patent for Vesimune

  BIOGGIO, Switzerland Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and infectious diseases, announced today that it has been granted the...

View Article

Image may be NSFW.
Clik here to view.

NeuroMetrix CEO to Present at 29th Annual Meeting of Japan Society of...

  WALTHAM, Mass. NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29th Annual Meeting of...

View Article

Image may be NSFW.
Clik here to view.

Gilead Submits New Drug Application to Japan’s Pharmaceutical and Medical...

  FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has submitted a New Drug Application (NDA) to Japan’s Pharmaceutical and Medical Devices Agency (PMDA) for...

View Article


Image may be NSFW.
Clik here to view.

U.S. FDA Accepts Otsuka and Lundbeck’s Filing for Review of Brexpiprazole for...

  TOKYO, Japan & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced that the U.S. Food and Drug Administration (FDA) has determined that the New...

View Article

Image may be NSFW.
Clik here to view.

Dr. Reddy’s Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP

  HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Levalbuterol Inhalation Solution, USP 0.31 mg /3 mL, 0.63 mg /3 mL, 1.25 mg / 3 mL Unit-Dose Vials, a...

View Article


Image may be NSFW.
Clik here to view.

Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing...

  DEERFIELD, Ill. & CAMBRIDGE, Mass. Baxter International Inc. (NYSE:BAX) and Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today jointly announced an exclusive license and collaboration agreement...

View Article

Image may be NSFW.
Clik here to view.

Vital Capital Announces $10 M Investment in WaterHealth International

  NEW YORK Vital Capital (www.vital-capital.com) announced today an investment of USD $10 million in a US company, WaterHealth International (“WHI”), a global leader in providing sustainable...

View Article


Image may be NSFW.
Clik here to view.

Blaze Bioscience Announces Initiation of Phase 1b Brain Cancer Program for...

  SEATTLE Blaze Bioscience, Inc., a biotechnology company focused on guided cancer therapy, announced today that the company has received clearance from the United States Food and Drug Administration...

View Article

Image may be NSFW.
Clik here to view.

NovaBay Receives First Large NeutroPhase Order From China Pioneer Pharma

  EMERYVILLE, Calif. NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today...

View Article

Image may be NSFW.
Clik here to view.

EPIRUS and Livzon Mabpharm, Inc. Enter Collaboration Agreement for China

  BOSTON EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies,...

View Article
Browsing all 7771 articles
Browse latest View live